Poland's law on cheap drugs declared contrary to EU law

A Polish law which allowed the sale of unapproved drugs which were cheaper than those approved has been declared contrary to EU law.

The decision by the Court of Justice of the European Union is discussed by EIP's Darren Smyth in his latest IPKat post.

Darren Smyth chairs CIPA lecture on Japanese biotech and pharma patent law

Partner Darren Smyth chaired a lecture for CIPA members on Japanese Patent Law and Practice in biotechnology and pharmaceutical technology on 17 April. The lecture took place at CIPA in Chancery Lane, London, and was led by Ayako Kobayashi, a Japanese...

Registered Community Designs: reasons for refusal

The OHIM has begun publishing information about Registered Community Design applications that have been refused. The designs themselves are not shown, but the grounds for refusal are now being made available. Darren Smyth relates the news in his lates...

Andrew Sharples and Darren Smyth hold workshop on SPC strategy

Partners Andrew Sharples and Darren Smyth will hold a pre-conference workshop at the C5 11th International Forum of Pharma Patent Lifecycles on 19 June. The two-day event will focus on recent cases across Europe and the US and their impact on the late...

Chemistry World: proposals for a unitary European patent, by Darren Smyth

Darren Smyth, head of EIP Elements, writes in the April issue of Chemistry World about the ongoing proposals for a unitary European patent. In an opinion article, Darren highlights the flaws with the current system and outlines the situation concernin...

Poland's law on cheap drugs declared contrary to EU law

Our cookies

Essential

Analytics

Social media & third party